MESOBLAST LTD (MESO) — SEC Filings

Latest SEC filings for MESOBLAST LTD (MESO), explained in plain English.

Sentiment Overview: 4 neutral

Recent Filings (4)

• Mesoblast Ltd. Presents R&D Day Updates — 6-K · 2026-04-08T07:18:45-04:00 [neutral] Risk: medium
  On April 8, 2026, Mesoblast Ltd. filed a 6-K report detailing presentations from their R&D Day. The company showcased advancements in their stem cell therapies,
• Mesoblast Ltd. Files 6-K Report with SEC — 6-K · 2026-04-08T06:18:54-04:00 [neutral] Risk: low
  On April 8, 2026, Mesoblast Ltd. filed a Form 6-K, reporting information to the SEC. The filing includes an express press release and exhibits, with the total s
• 6-K Filing — 6-K · 2026-04-08T06:17:07-04:00 [neutral]
• Mesoblast Ltd. Files Form 6-K with Updates — 6-K · 2026-04-08T06:15:11-04:00 [neutral] Risk: low
  Mesoblast Ltd. filed a Form 6-K on April 8, 2026, reporting information as a foreign issuer. The filing includes various exhibits, such as press releases and ap